# POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors

> **NCT04193956** · — · RECRUITING · sponsor: **University Medical Center Groningen** · enrollment: 3500 (estimated)

## Conditions studied

- Melanoma
- Non-Small Cell Lung Cancer

## Interventions

- **OTHER:** Standard-of-care procedures
- **OTHER:** Study procedures

## Key facts

- **NCT ID:** NCT04193956
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2018-08-01
- **Primary completion:** 2024-09
- **Final completion:** 2024-09
- **Target enrollment:** 3500 (ESTIMATED)
- **Last updated:** 2024-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04193956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04193956, "POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04193956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*